Year archive

IMMUTEP LIMITED — 2014 filings

All 72 regulatory filings released by IMMUTEP LIMITED (IMM) in 2014, sourced directly from the official regulator.

72 Filings

2014 Period

2014 filings (72)

Filing	Released	Lang
Prima receives NASDAQ deficiency notice 2 pages 136.0KB Regulatory Filings	2014-12-28	English
Notice of Grant received from Canadian Patent Office 2 pages 213.8KB Regulatory Filings	2014-12-21	English
Prima completes acquisition of Immutep 2 pages 212.6KB M&A Activity	2014-12-16	English
Prima initiates Pancreatic Clinical Trial with CVac 3 pages 220.8KB Regulatory Filings	2014-12-14	English
Cleansing Notice & Appendix 3B 14 pages 687.7KB Share Issue/Capital Change	2014-12-11	English
Appendix 3B 13 pages 657.4KB Capital/Financing Update	2014-12-11	English
Cleansing Notice & Appendix 3B 14 pages 688.1KB Capital/Financing Update	2014-12-10	English
Enhancement of manufacturing and logistics capabilities 2 pages 208.7KB Capital/Financing Update	2014-12-04	English
Appendix 3B 14 pages 678.6KB Capital/Financing Update	2014-11-27	English
Change of Director's Interest Notice 3 pages 323.8KB Director's Dealing	2014-11-27	English
2014 AGM Chairman's Address 2 pages 208.3KB AGM Information	2014-11-13	English
2014 AGM Presentations 33 pages 1.7MB AGM Information	2014-11-13	English
Results of Meeting 4 pages 203.9KB Declaration of Voting Results & Voting Rights Announcements	2014-11-13	English
Society for Immunotherapy of Cancer poster presentation 1 Regulatory Filings	2014-11-09	English
CVac demonstrates overall survival benefit 2 pages 231.3KB Regulatory Filings	2014-11-05	English
Cleansing Notice & Appendix 3B 10 pages 503.9KB Capital/Financing Update	2014-11-05	English
Supplemental Information for Shareholder Conference Call 21 pages 849.3KB Call Transcript	2014-10-22	English
Appendix 4C - quarterly 5 pages 329.8KB Interim / Quarterly Report	2014-10-20	English
Conference Call to discuss acquisition of Immutep 2 pages 216.5KB Capital/Financing Update	2014-10-20	English
Notice of Allowance for IMP321 Patent 2 pages 212.2KB Regulatory Filings	2014-10-13	English
Notice of Annual General Meeting/Proxy Form 27 pages 659.1KB AGM Information	2014-10-12	English
Prima Newsletter 6 pages 1.1MB Investor Presentation	2014-10-12	English
Annual Report on Form 20-F filed with SEC 112 pages 1.2MB Annual Report	2014-10-09	English
Annual Report to Shareholders 112 pages 2.6MB Annual Report	2014-10-09	English
Proposed Acquisition of Immutep 4 pages 241.1KB Merger & Acquisition	2014-10-01	English
Prima secures funding from US institutional investor 4 pages 245.9KB Capital/Financing Update	2014-10-01	English
Cleansing Notice & Appendix 3B 11 pages 532.1KB Share Issue/Capital Change	2014-10-01	English
Appendix 3B 8 pages 413.6KB Capital/Financing Update	2014-09-18	English
Appendix 4E & 2014 Full Year Statutory Accounts 81 pages 795.4KB Regulatory Filings	2014-08-26	English
Prima to present at Society for Immunotherapy of Cancer 1 Regulatory Filings	2014-08-18	English
Appendix 4C - quarterly 5 pages 367.9KB Interim / Quarterly Report	2014-07-30	English
Prima Newsletter 8 pages 636.9KB Management Reports	2014-07-30	English
CEO Terms of Employment 2 pages 212.6KB Board/Management Information	2014-07-21	English
Prima receives US patent grant for CVac 2 pages 208.9KB Regulatory Filings	2014-07-15	English
Final Director's Interest Notice 2 pages 199.5KB Director's Dealing	2014-07-14	English
Initial Director's Interest Notice 2 pages 186.4KB Director's Dealing	2014-07-14	English
Prima appoints new CEO 2 pages 212.2KB Board/Management Information	2014-07-08	English
Journal for Immunotherapy of Cancer Publication 1 p Regulatory Filings	2014-06-22	English
Prima to present at 2014 WAGO Annual Meeting 2 pages 209.6KB AGM Information	2014-06-18	English
Transcript of CAN-003 data conference call 10 pages 189.0KB Call Transcript	2014-06-03	English
CVac demonstrates positive trend in Overall Survival 2 pages 228.2KB Regulatory Filings	2014-06-01	English
Q&A with Dr Gray on CAN-003 data presented at ASCO 3 pages 515.5KB Investor Presentation	2014-06-01	English
Supplemental information for CAN-003 data conference call 13 pages 625.3KB Investor Presentation	2014-06-01	English
Conference call to discuss CAN-003 data presented at ASCO 2 pages 341.5KB Call Transcript	2014-05-29	English
USA Patent for CVac Allowed 1 page 207.4KB Regulatory Filings	2014-05-25	English
CVac demonstrates clinically meaningful improvement in PFS 3 pages 232.2KB Regulatory Filings	2014-05-14	English
Prima BioMed's CVac granted Fast Track Designation by FDA 2 pages 333.0KB Regulatory Filings	2014-05-08	English
Supplemental Information for Quarterly Conference Call 9 pages 628.0KB Interim / Quarterly Report	2014-05-05	English
Prima Newsletter 6 pages 333.1KB Investor Presentation	2014-05-04	English
Appendix 4C - quarterly 5 pages 368.7KB Interim / Quarterly Report	2014-04-28	English
Third Quarter Conference Call 2 pages 230.6KB Call Transcript	2014-04-28	English
Prima commences recruitment for CAN 004 Phase 2 trial 2 pages 211.9KB Regulatory Filings	2014-04-27	English
Prima to present at Needham Healthcare Conference 1 Investor Presentation	2014-04-06	English
CVac Improvement in 2nd Remission Data Accepted for ASCO 2 pages 210.8KB Regulatory Filings	2014-03-27	English
New Appointments to Clinical Advisory Board 2 pages 216.0KB Board/Management Information	2014-03-24	English
$1.6 million R&D Tax Incentive Refund Received 1 pa Capital/Financing Update	2014-03-04	English
Prima to present at Wall Street Analyst Forum 2 pages 210.8KB Investor Presentation	2014-02-26	English
Prima to present at Regen Med Investor Day 2 pages 216.3KB Investor Presentation	2014-02-26	English
Prima and Neopharm execute final CVac licensing agreement 2 pages 210.5KB Capital/Financing Update	2014-02-20	English
Dr Monk to Join Prima BioMed Clinical Advisory Board 2 pages 214.5KB Board/Management Information	2014-02-19	English
Half Yearly Report and Accounts 22 pages 2.6MB Regulatory Filings	2014-02-17	English
Appendix 3Z 2 pages 198.9KB Director's Dealing	2014-02-12	English
Appendix 3X 2 pages 195.8KB Director's Dealing	2014-02-12	English
Appointment & Retirement of Non-Executive Director 2 pages 210.5KB Board/Management Information	2014-02-11	English
CAN-004 Amendment Approved in Multiple Jurisdictions 2 pages 210.7KB Regulatory Filings	2014-02-05	English
Supplemental Information for Quarterly Conference Call 5 pages 317.4KB Interim / Quarterly Report	2014-02-05	English
Prima to present at Annual BIO CEO & Investor Conference 1 Investor Presentation	2014-01-30	English
Appendix 4C - quarterly 5 pages 369.9KB Interim / Quarterly Report	2014-01-28	English
Second Quarter Highlights and Conference Call 3 pages 487.0KB Interim / Quarterly Report	2014-01-28	English
Appendix 3B 8 pages 410.8KB Capital/Financing Update	2014-01-23	English
CAN-004 Clinical Trial Amendment Approved in Belgium 2 pages 210.5KB Regulatory Filings	2014-01-16	English
Prima CEO to be interviewed on live US Radio Show 2 pages 387.2KB Regulatory Filings	2014-01-08	English

Filings by year

2026 29 filings
2025 65 filings
2024 98 filings
2023 83 filings
2022 84 filings
2021 109 filings
2020 111 filings
2019 84 filings
2018 69 filings
2017 6 filings
2016 48 filings
2015 97 filings
2014 72 filings
2013 104 filings
2012 59 filings
2011 113 filings
2010 91 filings
2009 93 filings
2008 41 filings
2007 55 filings
2006 44 filings
2005 56 filings
2004 84 filings
2003 75 filings
2002 10 filings